Bristol Myers Squibb (CELG-RI) Shareholder's Equity (QoQ) (2009 - 2026)

Bristol Myers Squibb (CELG-RI) Shareholder's Equity (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.63%
Dec 31, 2025 -0.68%
Sep 30, 2025 34,344.44%
Jun 30, 2025 -81.51%
Mar 31, 2025 -98.04%
Dec 31, 2024 5,006.85%
Sep 30, 2024 0.00%
Jun 30, 2024 100.67%
Mar 31, 2024 -2,726.46%
Dec 31, 2023 -105.48%
Sep 30, 2023 171.11%
Jun 30, 2023 -13,689.04%
Mar 31, 2023 122.79%
Dec 31, 2022 -52.32%
Sep 30, 2022 97.62%
Jun 30, 2022 -54,395.38%
Mar 31, 2022 -99.73%
Dec 31, 2021 -46.22%
Sep 30, 2021 15,068.49%
Jun 30, 2021 -99.33%